SKI Market

Indian Indices

Sensex

82,274.66 -1,020.00
( -1.22%)

Global Indices

Nasdaq

48,816.07 -830.91
(-1.67%)

Dow Jones

6,858.07 -72.44
(-1.05%)

Hang Seng

57,337.44 511.74
(0.90%)

Nikkei 225

10,664.46 -22.43
(-0.21%)

Forex

USD-INR

90.72 -0.31
(-0.34%)

EUR-INR

106.89 -0.33
(-0.31%)

GBP-INR

122.26 -0.41
(-0.34%)

JPY-INR

0.59 0.00
(-0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

40.95

808.68

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.22

Back

PTL Enterprises standalone net profit rises 6.31% in the December 2025 quarter

Feb 05,2026

Net profit of PTL Enterprises rose 6.31% to Rs 8.93 crore in the quarter ended December 2025 as against Rs 8.40 crore during the previous quarter ended December 2024. Sales remain constant at Rs 16.09 crore in the quarter ended December 2025 and also during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	16.09	16.09	0
OPM %	89.68	90.68	-
PBDT	13.37	13.39	0
PBT	12.81	12.87	0
NP	8.93	8.40	6

82,274.66 -1,020.00 ( -1.22%)

48,816.07 -830.91 (-1.67%)

6,858.07 -72.44 (-1.05%)

57,337.44 511.74 (0.90%)

10,664.46 -22.43 (-0.21%)

90.72 -0.31 (-0.34%)

106.89 -0.33 (-0.31%)

122.26 -0.41 (-0.34%)

0.59 0.00 (-0.41%)